<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>BioC-API</source><date>20260212</date><key>collection.key</key><document><id>PMC12853465</id><infon key="license">CC BY-NC</infon><passage><infon key="article-id_doi">10.1136/bmjgast-2025-002122</infon><infon key="article-id_pmc">PMC12853465</infon><infon key="article-id_pmid">41577371</infon><infon key="article-id_publisher-id">bmjgast-2025-002122</infon><infon key="elocation-id">e002122</infon><infon key="issue">1</infon><infon key="kwd">INFLAMMATORY BOWEL DISEASE HEALTH SERVICE RESEARCH IBD IBD CLINICAL</infon><infon key="license">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/.</infon><infon key="name_0">surname:Mulligan;given-names:Robert J</infon><infon key="name_1">surname:Ryan;given-names:Pat</infon><infon key="name_10">surname:Bayliss;given-names:Sarah</infon><infon key="name_100">surname:Koumoutsos;given-names:Ioannis</infon><infon key="name_101">surname:Lamb;given-names:Christopher A</infon><infon key="name_102">surname:Lewis;given-names:Lianne</infon><infon key="name_103">surname:Lindsay;given-names:James O</infon><infon key="name_104">surname:Lloyd;given-names:Amy</infon><infon key="name_105">surname:Lock;given-names:Caroline</infon><infon key="name_106">surname:Ludlow;given-names:Helen</infon><infon key="name_107">surname:Macpherson;given-names:Clare</infon><infon key="name_108">surname:Macrae;given-names:Anne</infon><infon key="name_109">surname:Mairs;given-names:Philip</infon><infon key="name_11">surname:Bell;given-names:Graham</infon><infon key="name_110">surname:Martin;given-names:Gayle</infon><infon key="name_111">surname:Mason;given-names:Joy</infon><infon key="name_112">surname:Mccaul;given-names:Kirsten</infon><infon key="name_113">surname:Mcfarlane;given-names:Gordon</infon><infon key="name_114">surname:McGettigan;given-names:Ross</infon><infon key="name_115">surname:Morgan;given-names:Vidya</infon><infon key="name_116">surname:Morris;given-names:Deborah</infon><infon key="name_117">surname:Morrison;given-names:Graham</infon><infon key="name_118">surname:Mudege;given-names:Themba</infon><infon key="name_119">surname:Muir;given-names:Ann</infon><infon key="name_12">surname:Bone;given-names:Kathleen</infon><infon key="name_120">surname:Nahal;given-names:Jasbir</infon><infon key="name_121">surname:Narain;given-names:Mark</infon><infon key="name_122">surname:Nellikunnil;given-names:Ebenezer</infon><infon key="name_123">surname:Nelson;given-names:Elizabeth</infon><infon key="name_124">surname:Nowell;given-names:Emma</infon><infon key="name_125">surname:Oglesby;given-names:Arabis</infon><infon key="name_126">surname:Owens;given-names:Joanne</infon><infon key="name_127">surname:Padmanabhan;given-names:Hari</infon><infon key="name_128">surname:Parkin;given-names:Lauren Laydon</infon><infon key="name_129">surname:Paterson;given-names:Jacqueline</infon><infon key="name_13">surname:Buckley;given-names:Seema</infon><infon key="name_130">surname:Pavlidis;given-names:Polychronis</infon><infon key="name_131">surname:Peake;given-names:Simon</infon><infon key="name_132">surname:Peerally;given-names:Mohammad Farhad</infon><infon key="name_133">surname:Phillis;given-names:Kathryn</infon><infon key="name_134">surname:Raine;given-names:Tim</infon><infon key="name_135">surname:Rawle;given-names:Maxine</infon><infon key="name_136">surname:Ray;given-names:Shuvra</infon><infon key="name_137">surname:Reilly;given-names:Ian</infon><infon key="name_138">surname:Robinson;given-names:Kerry</infon><infon key="name_139">surname:Robinson;given-names:Jenna</infon><infon key="name_14">surname:Chana;given-names:Angela</infon><infon key="name_140">surname:Rutter;given-names:Matthew D</infon><infon key="name_141">surname:Tuck;given-names:Linda Samuel</infon><infon key="name_142">surname:Scott;given-names:Glyn</infon><infon key="name_143">surname:Sebastian;given-names:Shaji</infon><infon key="name_144">surname:Selinger;given-names:Christian P</infon><infon key="name_145">surname:Sharratt;given-names:Caroline</infon><infon key="name_146">surname:Shaw;given-names:Ian</infon><infon key="name_147">surname:Slater;given-names:Jayne</infon><infon key="name_148">surname:Smith;given-names:Melissa A</infon><infon key="name_149">surname:Smith;given-names:Samuel</infon><infon key="name_15">surname:Fraser Cummings;given-names:J R</infon><infon key="name_150">surname:Smith;given-names:Katie</infon><infon key="name_151">surname:Somasekar;given-names:Amudha</infon><infon key="name_152">surname:Sonwalkar;given-names:Sunil</infon><infon key="name_153">surname:Squires;given-names:Seth</infon><infon key="name_154">surname:Steel;given-names:Alan</infon><infon key="name_155">surname:Sunil;given-names:Samuel</infon><infon key="name_156">surname:Sutherland;given-names:Diarmid</infon><infon key="name_157">surname:Thoua;given-names:Nora</infon><infon key="name_158">surname:Upton;given-names:Diane</infon><infon key="name_159">surname:Veryan;given-names:Jennifer</infon><infon key="name_16">surname:Din;given-names:Shahida</infon><infon key="name_160">surname:Waters;given-names:Aldea</infon><infon key="name_161">surname:Wen;given-names:Susie</infon><infon key="name_162">surname:White;given-names:Lydia</infon><infon key="name_163">surname:Whiteoak;given-names:Simon R</infon><infon key="name_164">surname:Wilcox;given-names:Sarra</infon><infon key="name_165">surname:Younge;given-names:Lisa</infon><infon key="name_166">surname:Younge;given-names:Pam</infon><infon key="name_167">surname:Brookes;given-names:Matthew J</infon><infon key="name_168">surname:Hawthorne;given-names:A Barney</infon><infon key="name_169">surname:Lamb;given-names:Christopher A</infon><infon key="name_17">surname:Dobson;given-names:Liz</infon><infon key="name_18">surname:Eldridge;given-names:Fiona</infon><infon key="name_19">surname:Evans;given-names:Jonathan</infon><infon key="name_2">surname:Beck;given-names:Lauren C</infon><infon key="name_20">surname:Ganendran;given-names:Melissa</infon><infon key="name_21">surname:Harrison;given-names:Wendi</infon><infon key="name_22">surname:Barney Hawthorne;given-names:A</infon><infon key="name_23">surname:Keetarut;given-names:Katie</infon><infon key="name_24">surname:Kent;given-names:Alexandra</infon><infon key="name_25">surname:Kwok;given-names:Jon</infon><infon key="name_26">surname:Lamb;given-names:Christopher A</infon><infon key="name_27">surname:Limdi;given-names:Jimmy K</infon><infon key="name_28">surname:Maxwell-Armstrong;given-names:Charles</infon><infon key="name_29">surname:Martin;given-names:Gayle</infon><infon key="name_3">surname:Christiansen;given-names:Paul</infon><infon key="name_30">surname:Parkes;given-names:Gareth C</infon><infon key="name_31">surname:Pryde;given-names:Emma</infon><infon key="name_32">surname:Quraishi;given-names:Mohammed Nabil</infon><infon key="name_33">surname:Radcliffe;given-names:Marianne</infon><infon key="name_34">surname:Rees;given-names:Fiona</infon><infon key="name_35">surname:Robinson;given-names:Jenna</infon><infon key="name_36">surname:Rudling;given-names:Ruth</infon><infon key="name_37">surname:Selinger;given-names:Christian P</infon><infon key="name_38">surname:Sharma;given-names:Esha</infon><infon key="name_39">surname:Sleet;given-names:Sarah</infon><infon key="name_4">surname:Turner;given-names:Jessica</infon><infon key="name_40">surname:Skipp;given-names:Ben</infon><infon key="name_41">surname:Thomas;given-names:Anwen</infon><infon key="name_42">surname:Turner;given-names:Jessica</infon><infon key="name_43">surname:Wakeman;given-names:Ruth</infon><infon key="name_44">surname:Younge;given-names:Lisa</infon><infon key="name_45">surname:Winsor;given-names:Catherine</infon><infon key="name_46">surname:Afifi;given-names:Mostafa</infon><infon key="name_47">surname:Aitchison;given-names:Lucy</infon><infon key="name_48">surname:Anderson;given-names:Gill</infon><infon key="name_49">surname:Bain;given-names:Gillian</infon><infon key="name_5">surname:Selinger;given-names:Christian P</infon><infon key="name_50">surname:Bayaty;given-names:Zahra</infon><infon key="name_51">surname:Bell;given-names:Pauline</infon><infon key="name_52">surname:Berrill;given-names:James</infon><infon key="name_53">surname:Bishop;given-names:Sophia</infon><infon key="name_54">surname:Blaker;given-names:Paul</infon><infon key="name_55">surname:Bodger;given-names:Keith</infon><infon key="name_56">surname:Broomhall;given-names:Dulini</infon><infon key="name_57">surname:Burn;given-names:Victoria</infon><infon key="name_58">surname:Butterworth;given-names:Jeffrey R</infon><infon key="name_59">surname:Cairnes;given-names:Vida</infon><infon key="name_6">surname:Cummings;given-names:J R Fraser</infon><infon key="name_60">surname:Campbell;given-names:Rachel</infon><infon key="name_61">surname:Carris-Wright;given-names:Julie</infon><infon key="name_62">surname:Castillo;given-names:Rowena</infon><infon key="name_63">surname:Caulfield;given-names:Louise</infon><infon key="name_64">surname:Cheshire;given-names:Alex</infon><infon key="name_65">surname:Chohan;given-names:Daljit</infon><infon key="name_66">surname:Clark;given-names:Marion</infon><infon key="name_67">surname:Clark;given-names:Katie</infon><infon key="name_68">surname:Cobb;given-names:Carol</infon><infon key="name_69">surname:Coe;given-names:Josephine</infon><infon key="name_7">surname:Adams;given-names:Katie</infon><infon key="name_70">surname:Cooney;given-names:Rachel</infon><infon key="name_71">surname:Cumlat;given-names:Lourdes</infon><infon key="name_72">surname:Daly;given-names:Patricia</infon><infon key="name_73">surname:De Silva;given-names:Anups</infon><infon key="name_74">surname:Dhar;given-names:Anjan</infon><infon key="name_75">surname:Disney;given-names:Benjamin</infon><infon key="name_76">surname:Donovan;given-names:Fiona</infon><infon key="name_77">surname:Empson;given-names:Helen</infon><infon key="name_78">surname:Fraser;given-names:Bridgette</infon><infon key="name_79">surname:Fraser;given-names:Aileen</infon><infon key="name_8">surname:Ainley;given-names:Rachel</infon><infon key="name_80">surname:George;given-names:Becky</infon><infon key="name_81">surname:Ghosh;given-names:Nivedita</infon><infon key="name_82">surname:Gray;given-names:Lynn</infon><infon key="name_83">surname:Gulliver;given-names:James</infon><infon key="name_84">surname:Gunasekera;given-names:Anton</infon><infon key="name_85">surname:Gwiggner;given-names:Markus</infon><infon key="name_86">surname:Harrison;given-names:Sarah</infon><infon key="name_87">surname:Harrison;given-names:Wendi</infon><infon key="name_88">surname:Hay;given-names:Virginia</infon><infon key="name_89">surname:Hayhurst;given-names:Caroline</infon><infon key="name_9">surname:Arnott;given-names:Ian</infon><infon key="name_90">surname:Hooper;given-names:Patricia</infon><infon key="name_91">surname:Horne;given-names:Louise</infon><infon key="name_92">surname:Jafferbhoy;given-names:Hasnain</infon><infon key="name_93">surname:Johns;given-names:Kerrie</infon><infon key="name_94">surname:Johnston;given-names:Emma</infon><infon key="name_95">surname:Kemp;given-names:Karen</infon><infon key="name_96">surname:Kilpatrick;given-names:Dawn</infon><infon key="name_97">surname:Kirkbride;given-names:Matthew</infon><infon key="name_98">surname:Kirkham;given-names:Beverley</infon><infon key="name_99">surname:Kneebone;given-names:Andrew</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">13</infon><infon key="year">2026</infon><offset>0</offset><text>Research engagement and patient-reported quality of care: a cross-sectional study of UK inflammatory bowel disease services</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>124</offset><text>Abstract</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>133</offset><text>Objective</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>143</offset><text>Across several clinical specialties, research-active hospitals deliver higher-quality care and achieve better patient outcomes. To date, these associations have primarily been demonstrated using hospital-reported metrics, with limited insight from the patient perspective. This study evaluated, for the first time, the association between research activity within UK inflammatory bowel disease (IBD) hospital services and adult patient-reported quality of care.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>605</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>613</offset><text>A cross-sectional analysis was conducted using 2023 national IBD UK benchmarking Patient and Service Survey data linked with research recruitment metrics from the National Institute for Health and Care Research Central Portfolio Management System (CPMS) between 2020 and 2022. Patient-reported high-quality care in the preceding 12 months was defined as a response of ‘good’, ‘very good’ or ‘excellent’ on a five-point Likert scale. Research activity was measured by the number of participants recruited to CPMS-registered IBD studies managed by gastroenterology. Associations were assessed using Spearman’s correlation and multivariate regression, adjusting for service-level factors.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1313</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1321</offset><text>Recruitment data from 32 391 research participants across 176 IBD services were aligned with 11 454 care quality and 13 583 research opportunity patient responses. A positive correlation was observed between IBD service research recruitment volume and the proportion of patients reporting high-quality care (rₛ=0.19, p=0.013). This association remained significant after adjusting for tertiary status, service size, number of consultants and presence of an IBD leadership team (adjusted β (SE)=0.0008 (0.0004); p=0.029). Services recruiting to interventional studies demonstrated higher patient-reported care quality, while those offering research opportunities reported both higher care quality and greater research recruitment.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>2060</offset><text>Conclusion</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>2071</offset><text>IBD service research activity is positively associated with patient-reported care quality. Embedding research engagement within routine service delivery may improve patient experience and support quality improvement. The results have important implications for service design, workforce planning and national research policy.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2397</offset><text>WHAT IS ALREADY KNOWN ON THIS TOPIC</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2433</offset><text>Research-active hospitals have improved patient outcomes in areas such as oncology, cardiology and acute care.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2544</offset><text>Previous studies have primarily relied on objective institutional metrics of care quality, with limited input from the patient perspective.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2684</offset><text>WHAT THIS STUDY ADDS</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2705</offset><text>Inflammatory bowel disease (IBD) services across the UK that recruited more patients to research studies were associated with greater patient-reported high-quality care.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2875</offset><text>This is, to our knowledge, the first study to examine the relationship between research engagement and care quality in a chronic disease, such as IBD, and to do so from the perspective of service users.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>3078</offset><text>HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3135</offset><text>These findings strengthen the case for integrating research activity into routine clinical practice.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3236</offset><text>They support national investment in research infrastructure, resources and policy as a strategy to enhance patient experience and care quality.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>3380</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3393</offset><text> Engagement with research has been shown to be associated with improved patient outcomes and organisational performance at an institutional level. In the UK, hospitals with greater patient recruitment to interventional research studies have attained better Care Quality Commission ratings and lower Summary Hospital-level Mortality Indicator scores. Hospital Episode Statistics data in England similarly show a lower risk-adjusted mortality for acute admissions to research-active hospitals, a finding that persisted after adjustment for staffing and other structural factors.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3970</offset><text>Comparable findings have been reported across specific disease areas. For example, hospitals with higher participation in interventional colorectal cancer clinical trials demonstrated lower postoperative mortality and improved 5-year survival rates, independent of other hospital characteristics. Similarly, cardiology patients with acute myocardial infarction admitted to hospitals recruiting to clinical trials experienced lower in-hospital mortality and fewer 1 year major adverse cardiovascular events compared with hospitals not engaged in research.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4527</offset><text>Notably, the patient perspective has rarely been considered in studies examining the relationship between organisational research activity and care quality, which have predominantly relied on objective hospital-reported outcomes. Although patients admitted to research-active hospitals report greater confidence in staff and higher satisfaction with information about their care, the direct association between research activity and patient-reported care quality has not been thoroughly assessed.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5024</offset><text>In inflammatory bowel disease (IBD), the relationship between research activity and quality of care, either hospital-reported or patient-reported, has remained underexplored. The 2019 national IBD UK benchmarking Patient and Service Surveys identified that the availability of research opportunities was among the hospital service factors associated with patient-reported high-quality care. However, less subjective markers of research activity, such as the relationship between the volume of research recruitment within IBD services and patient-reported care quality, have not yet been formally examined. Given the strong evidence from other specialties, and the preliminary IBD-specific findings, we hypothesised that IBD services with higher research activity—measured by the number of patients recruited to research studies—would also have a greater proportion of patients reporting their care as high quality.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5943</offset><text>Further national IBD UK Patient and Service Surveys were conducted in 2023, capturing patient-reported care quality across IBD services in England, Scotland, Northern Ireland and Wales, while also providing more granular detail on research opportunities and their availability to patients.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6233</offset><text>The primary aim of the present study was to evaluate the relationship between patient-reported high-quality care across UK IBD services and research activity, measured by recruitment to interventional and observational research studies identified through the National Institute of Health and Care Research Central Portfolio Management System (NIHR CPMS) registry. The secondary aim of this research was to explore the relationships between patient-reported high-quality care, whether patients were offered the opportunity to participate in research and NIHR CPMS recruitment data.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6814</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6822</offset><text>National IBD UK benchmarking and patient-reported quality of care</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6888</offset><text>This retrospective analysis utilised data from the nationwide 2023 IBD UK benchmarking, which included a Patient Survey completed by individuals living with IBD between April and June 2023, and a Service Survey completed by individual IBD hospital services between June and August 2023. IBD UK comprises 16 patient organisations, professional bodies and Royal Colleges, representing all stakeholders in IBD care across the UK, and has a mission to ensure that all people living with IBD receive safe, consistent, high-quality and personalised care.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7437</offset><text>The 2023 IBD UK Patient and Service Surveys are based on the 2019 IBD Standards, a document that describes the optimal design and delivery of IBD services in the UK and includes metrics by which care quality can be measured and compared between service providers. These surveys were adapted from the initial national benchmarking process undertaken in 2019–2020. Notably, they enable the parallel assessment of hospital-reported information and metrics regarding IBD services, as well as the experiences of those who access the service. Completion of the 2023 Surveys was promoted through printed materials in IBD clinics, targeted emails, social media platforms and the IBD UK website. A report, ‘The State of IBD care in the UK’ summarising data from the 2023 Surveys was launched in the UK House of Lords in December 2024.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8269</offset><text>As part of the Patient Survey, respondents rated the quality of their IBD care over the past 12 months using a five-point Likert scale (‘poor’, ‘fair’, ‘good’, ‘very good’ or ‘excellent’). Patient-reported ‘high-quality care’ was defined as responses of good, very good or excellent, and the proportion of patients reporting high-quality care was calculated as a percentage of total respondents from each service. Only adult services with at least five responses to the quality-of-care question were included in this analysis.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8820</offset><text>The IBD Service Survey was a hospital self-assessment questionnaire completed by IBD services and captured information about service structure and workforce provision. This included variables that have been previously shown to be associated with patient-reported care quality, including the presence of a tertiary centre, the number of IBD consultants, leadership team composition and estimation of the number of adult patients managed by the service.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9272</offset><text>IBD UK data were collected and managed using REDCap electronic data capture tools, hosted at the IBD Registry. IBD UK, Crohn’s &amp; Colitis UK and the IBD Registry designed and delivered the surveys. The IBD Registry coordinated data collection and acted as data controller. The data were shared with Crohn’s &amp; Colitis UK for analysis under a data-sharing agreement. All patient data was collected and analysed in an anonymous form.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9706</offset><text>NIHR CPMS national research recruitment data</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9751</offset><text>NIHR CPMS is a comprehensive national cloud-based system that hosts the NIHR Portfolio, as well as the network portfolios of Northern Ireland, Scotland and Wales. The CPMS is used to support study management, submit service requests and as a portal through which associated costing tools can be accessed.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10056</offset><text>The NIHR defines an observational study as one in which investigators do not seek to intervene but instead observe the course of events. In contrast, an interventional study is defined by the NIHR as a clinical study in which participants are assigned to receive one or more interventions (or no intervention), allowing researchers to evaluate the effects of the interventions on biomedical or health-related outcomes.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10475</offset><text>Using the CPMS database, the number of patients recruited to IBD studies was identified for each hospital from 1 January 2020 to 31 December 2022, the three calendar years leading up to the 2023 IBD UK Patient Survey. Recruitment data were manually attributed to corresponding IBD services. Only studies where gastroenterology was listed as the ‘managing specialty’ and IBD was the ‘primary subspecialty’ were included. This encompassed both observational and interventional studies, across commercial and non-commercial research. If the hospital or hospitals within an IBD service had no registered CPMS recruitment data, recruitment was recorded as zero.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11140</offset><text>Tertiary status data for each service were obtained primarily from the IBD UK Service Survey. Where this information was missing, it was supplemented using the NIHR CPMS database, which categorises recruiting hospitals as either secondary or tertiary centres.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>11400</offset><text>Identification of research opportunities offered within IBD services</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11469</offset><text>Patient Survey respondents were asked about research opportunities offered by their IBD team over the previous 12 months. The specific question posed was:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11624</offset><text>‘In the past 12 months, have your IBD team offered you any of the following opportunities to take part in clinical trial/s and/or IBD research?’. Participants were allowed to select multiple responses from the following options:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11857</offset><text>I received information about clinical trials and research.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11916</offset><text>I have been offered specific opportunities to participate in research.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11987</offset><text>My IBD team advertises opportunities in their waiting rooms/clinics.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12056</offset><text>My IBD team provides information on a website.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12103</offset><text>My IBD team shows me opportunities from national patient organisations or charities.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12188</offset><text>None of the above.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>12207</offset><text>Statistical analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12228</offset><text>Statistical analysis was performed using Prism V.10.5.0 (GraphPad Software, Boston, Massachusetts, USA), unless stated otherwise. Spearman’s rank correlation coefficient (rₛ) was used to assess relationships between continuous variables. Comparisons between two independent groups were made using the Mann-Whitney U test, while comparisons across more than two independent groups were conducted using the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Sensitivity analyses were performed by identifying outliers using an iterative Grubbs test with α=0.0001 to improve graphical representation and ensure reliable analysis. Multivariate statistical analysis was conducted using R V.4.5.0. Beta regression models with a logit link were fitted using the glmmTMB package (V.1.1.11) to examine the association between service-level characteristics and the proportion of high-quality care reported. A series of candidate models was specified to compare the impact of different explanatory variables. Missing values were excluded on a per-variable basis. Six models were fitted in total, each varying in combinations of predictors to assess model fit and explanatory power. Model performance was compared using Akaike Information Criterion and Bayesian Information Criterion. For each fitted model, diagnostic checks were performed using the DHARMa package (V.0.4.7). All diagnostics showed acceptable model fit, including the final model (online supplemental figure 1). This study is reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (see online supplemental material for the completed STROBE checklist).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>13926</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13934</offset><text>IBD-UK Patient and Service Survey data</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13973</offset><text>Across the UK, 17 006 adult patients responded to the 2023 IBD UK Patient Survey, and 126 IBD services completed the Service Survey. A comprehensive summary of the results from both components of the benchmarking surveys is available on the IBD UK website.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>14232</offset><text>Patient-reported quality of care</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14265</offset><text>Patient-reported quality of care data was available for 13 646 Patient Survey respondents. Of these, 11 454 (84%) were matched to 176 confirmed IBD services that had at least five patient survey responses and were therefore included in the analysis. The median number of patient responses to the quality-of-care question per IBD service was 56.5 (IQR: 34–84.5). The characteristics of the included IBD services are described in online supplemental table 1.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>14728</offset><text>Research opportunities offered within IBD services</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14779</offset><text>Research opportunity data was available for 14 653 Patient Survey respondents. Of these, 13 583 (93%) were attributed to the 176 included IBD services. The median number of responses per included service for research opportunities was 68 (IQR 41.25–104.3). A breakdown of the proportion of survey respondents from each IBD service who were offered each research opportunity is shown in figure 1.</text></passage><passage><infon key="file">bmjgast-13-1-g001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>15181</offset><text>(A) Proportion of respondents per IBD service reporting being offered each research opportunity in the 2023 IBD UK Patient Survey. (B) Proportion of respondents per IBD service reporting not being offered any of the listed research opportunities in the 2023 IBD UK Patient Survey. Each point represents an individual IBD service; each violin plot shows the distribution of proportions across services. Responses were from 13 583 respondents across 176 IBD services. IBD, inflammatory bowel disease.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>15682</offset><text>NIHR CPMS research recruitment</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15713</offset><text>Recruitment data were identified for 33 186 recruited patients. Recruitment was highest in 2020, with a marked decline in 2021 and 2022 (figure 2). The majority of patients (30 885; 93%) were recruited into observational studies, which predominated in all 3 years: 17 675 (97%) in 2020, 7148 (88%) in 2021 and 6062 (89%) in 2022.</text></passage><passage><infon key="file">bmjgast-13-1-g002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>16047</offset><text>Annual recruitment to National Institute for Health and Care Research Central Portfolio Management System (NIHR CPMS)-registered research studies, 2020–2022, stratified by study type (observational vs interventional). A total of 33 186 participants were recruited over 3 years.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16329</offset><text>Recruitment data for 32 391 patients (98% of all recruited patients) were successfully aligned with the 176 IBD services included in the analyses. Of these services, 111 (63%) services recruited exclusively to observational studies during the study period. Recruitment per site differed significantly between 2020 and both 2021 and 2022 (Dunn’s multiple comparisons test p&lt;0.0001), with a higher number of patients per site recruited in 2020 compared with the subsequent 2 years.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>16813</offset><text>Association between research recruitment and patient-reported high-quality care</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16893</offset><text>A significant positive correlation was observed between the number of patients recruited to research studies within an IBD service and the proportion of patients reporting high-quality care (rₛ=0.19, p=0.013, n=176 services). Using an iterative Grubb’s test with a significance level of α=0.0001, a total of six outlier services were identified based on total recruitment. The positive correlation between research recruitment and patient-reported care quality remained significant after outlier removal (rₛ=0.18, p=0.0203, n=170 services) (figure 3A). In addition, the association remained significant after a multivariate beta regression analysis, adjusting for service-level factors reported by the Service Survey, including tertiary status, number of patients cared for, number of IBD consultants and the presence of an IBD leadership team (adjusted β (SE)=0.0008 (0.0004); p=0.029).</text></passage><passage><infon key="file">bmjgast-13-1-g003.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>17789</offset><text>(A) Relationship between the number of patients within an IBD service recruited to National Institute for Health and Care Research Central Portfolio Management System (NIHR CPMS)-registered research studies (2020–2022) and the proportion of patients reporting high-quality care in the 2023 IBD UK Patient Survey. Each point represents an individual IBD service (n=170; six outliers removed using iterative Grubbs’ test). (B) Comparison of the proportion of patients reporting high-quality care in the 2023 IBD UK Patient Survey between IBD services that did and did not recruit to NIHR CPMS-registered interventional research studies (2020–2022). Each point represents an individual IBD service (n=176). IBD, inflammatory bowel disease.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>18532</offset><text>Association between research recruitment to observational and interventional studies with patient-reported high-quality care</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18657</offset><text>The positive association between research activity and patient-reported high-quality care persisted when analyses were stratified by study type. Specifically, recruitment to observational studies was significantly correlated with high-quality care (rₛ=0.19, p=0.0133, n=176 services), as was recruitment to interventional studies (rₛ=0.22, p=0.0032, n=176 services).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19028</offset><text>When stratified by study type, five outlier services were identified for observational recruitment, and 13 outlier services were identified for interventional recruitment. After outlier exclusion, the correlation with observational study recruitment remained significant (rₛ=0.19, p=0.0124, n=171 services). In contrast, the correlation with interventional recruitment was no longer statistically significant (rₛ=0.11, p=0.1479, n=163 services) (online supplemental figure 2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19509</offset><text>Notably, IBD services that recruited at least one patient to an interventional study (n=65 services) had a significantly higher median proportion of patients reporting high-quality care than those that did not (n=111) (68.1% vs 62.1%; Mann-Whitney p=0.01) (figure 3B).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>19778</offset><text>Association between research opportunities and patient-reported high-quality care</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19860</offset><text>Within the IBD UK Patient Survey dataset, positive correlations were observed between the proportion of patients offered research opportunities and the proportion of patients reporting high-quality care. This correlation was significant for each of the five opportunities within the survey (figure 4). In this analysis, one outlier service was identified in relation to the option ‘My IBD team provides information on a website’, with 17.6% of their respondents selecting this option compared with a median of 0.5% (IQR 0%–1.8%) across all services, and was therefore removed (figure 4D). A negative correlation was identified between the proportion of patients within a service who reported not being offered any of the listed research opportunities and the proportion of patients reporting high-quality care.</text></passage><passage><infon key="file">bmjgast-13-1-g004.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>20677</offset><text>Relationship between the proportion of respondents to the 2023 IBD UK Patient Survey within an IBD service reporting being offered each research opportunity and the proportion reporting high-quality care. (A) Received information about clinical trials and research; (B) offered specific opportunities to participate in research; (C) IBD team advertises opportunities in waiting rooms/clinics; (D) IBD team provides information on a website (one outlier excluded); (E) IBD team shows opportunities from national patient organisations or charities and (F) none of the above. IBD, inflammatory bowel disease.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>21283</offset><text>Association between research opportunities offered and research recruitment</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21359</offset><text>A significant positive correlation was observed between the proportion of patients reporting being offered research opportunities and the number of patients recruited to NIHR CPMS-registered research studies by that service between 2020 and 2022. This relationship was significant for all five research opportunities listed in the survey. Conversely, a significant negative correlation was identified between the proportion of patients within a service who reported not being offered any of the listed research opportunities and the number of patients recruited (online supplemental table 2). Six services were identified as outliers based on total recruitment to research studies, and one service was identified as an outlier specifically for the option ‘My IBD team provides information on a website’. After removing these outliers, the correlation between research opportunities offered and research recruitment remained significant for all options except ‘My IBD team provides information on a website’ (rs=0.15, p=0.052, n=169 services). The strongest relationships were seen for the options ‘I received information about clinical trials and research’ and ‘I have been offered specific opportunities to participate in research’ (figure 5).</text></passage><passage><infon key="file">bmjgast-13-1-g005.jpg</infon><infon key="id">F5</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>22620</offset><text>Relationship between the proportion of respondents to the 2023 IBD UK Patient Survey within an IBD service reporting being offered each research opportunity and the number of patients recruited to National Institute for Health and Care Research Central Portfolio Management System (NIHR CPMS)-registered research studies (2020–2022) after removal of outliers. (A) I received information about clinical trials and research. (B) I have been offered specific opportunities to participate in research. (C) My IBD team advertises opportunities in their waiting rooms/clinics. (D) My IBD team provides information on a website. (E) My IBD team shows me opportunities from national patient organisations or charities. (F) None of the above. IBD, inflammatory bowel disease.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>23389</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23400</offset><text>In this national study of adult IBD services across the United Kingdom, we identified that greater research activity within IBD services was positively associated with patient-reported high-quality care. This finding remained robust after adjusting for key service factors, including tertiary status, the number of patients cared for by the service, the number of IBD-interested gastroenterologists and the presence of an IBD leadership team. Our data highlight that fostering a research-engaged ethos benefits not only large academic centres but also district general hospitals and smaller services. Previous work has shown that hospitals engaging with research achieve improved outcomes in areas such as oncology, cardiology and acute care. To our knowledge, the present study is the first to explore this relationship in the management of a chronic condition such as IBD, and to do so using patient-reported rather than institutional measures of care quality.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24363</offset><text>A positive association between patient-reported quality of care and research activity was evident across both observational and interventional research activity. After excluding high-recruiting outliers, significance persisted only for observational recruitment. However, services participating in any interventional research showed significantly higher patient-reported quality of care compared with those that did not. This may, in part, reflect the availability of additional treatment options provided through clinical trials for patients refractory to licensed therapies, offering new hope and fostering confidence in care across the IBD service. Given that interventional research is resource-intensive, this finding highlights the broader value of investing in infrastructure to support clinical trial participation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25187</offset><text>Services offering more research opportunities were shown to have higher research recruitment and better patient-reported quality of care. Providing information about research and offering specific research opportunities showed the strongest link to increased recruitment. Broadening access to research may therefore represent both a clinical and strategic priority, simultaneously enhancing care quality while improving study recruitment. Furthermore, the finding that services where a greater proportion of IBD UK survey respondents reported being offered research opportunities also recruited more patients to NIHR CPMS-registered studies supports the validity and generalisability of the IBD UK benchmarking exercise.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25908</offset><text>In this study, we used data from the IBD UK Patient Survey, which was available to all patients, not just those taking part in research. Given that only a small proportion of IBD patients are typically recruited into studies, the associations in service-level care perceptions are unlikely to reflect direct experiences of research participants alone. Rather, they likely represent broader cultural and organisational effects of research engagement. Services that prioritise innovation and actively contribute to evidence-based practice may foster a more positive care environment overall. The associations may also reflect practical factors such as enhanced staffing or greater support resources, rather than the direct effects of research participation itself. In this context, research activity may act as a proxy for organisational excellence, encompassing strong leadership, effective communication and a proactive approach to quality improvement. In contrast, under-resourced and smaller units, where care is stretched through capacity, funding and time constraints, may struggle to engage with research in a sustained and meaningful way. These challenges and considerations are relevant to all services caring for patients with chronic conditions.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27163</offset><text>The findings of this study have direct implications for service design, workforce planning and national research policy. Embedding research into routine care and protecting time for research-involved professionals should be seen not just as academic or aspirational goals, but as practical strategies to enhance the quality of care experienced by patients. Staffing levels within units should also support sufficient time for service improvement and innovation. National bodies, including the NIHR, the British Society of Gastroenterology (BSG), and Crohn’s and Colitis UK, play a key role in strengthening research infrastructure and promoting research participation among clinicians and patients. Initiatives such as the NIHR Associate Principal Investigator Scheme and BSG trainee networks enable trainees and IBD nurses to engage meaningfully in research across tertiary and district general hospitals, while supporting research training and delivery. This study reinforces the value of investing in such initiatives, not only for professional development but also as a driver of improved patient care now and in the future.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28294</offset><text>Notably, national research recruitment in 2020 was significantly higher than in 2021 and 2022, largely due to the CLARITY IBD study (Impact of Biologic Therapy on SARS-CoV-2 Infection and Immunity), which recruited more than 7200 participants (40% of total 2020 recruitment) within 12 weeks. Designed to address urgent public health questions during the COVID-19 pandemic, the study employed innovative recruitment strategies supported by the NIHR. Although the pandemic disrupted research activity, the effect was mitigated by the NIHR restart framework published in May 2020. By January 2021, more than 60% of paused trials and studies had restarted. These measures helped minimise interruptions and ensure the findings of our study remain generalisable.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>29051</offset><text>The present study is strengthened by a large sample size, the use of two independent national datasets and the inclusion of longitudinal research recruitment data from three consecutive years (2020–2022), capturing both the COVID-19 pandemic and post-pandemic eras. Analyses extended beyond total recruitment numbers to distinguish observational and interventional studies, offering a more nuanced understanding of how research engagement may influence patient-reported quality of care. The incorporation of patient-reported data offers valuable insights into the perspectives of service users. Correlating these subjective perceptions of care quality with objective recruitment data underscores the dual benefit of research engagement for both service users and the wider research community. In this first national-level analysis directly comparing IBD research activity with patient-reported quality of care, the consistency of the associations observed supports the integration of research into everyday practice and strengthens the case for dedicated research infrastructure and clinician support.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>30155</offset><text>The present study is limited by a retrospective observational design, which inherently limits the ability to make causal inferences. Indeed, it is plausible that services delivering higher-quality care may also be more likely to engage in research. While we have attempted to control for available confounding factors, other unmeasured variables may have impacted both recruitment levels and patient-reported care quality. Additionally, the observed associations, although statistically significant, were relatively modest in strength and should be interpreted alongside other factors influencing care. Mapping recruitment data to IBD services was sometimes challenging when service structures changed during the study period, raising the possibility of misattributed recruitment. Additionally, survey-based measures are vulnerable to response bias. Finally, while our definition of ‘high-quality care’ provides a pragmatic binary stratification, identifying those who have a positive perception of the care they have received, a universally accepted definition of high-quality care is lacking.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>31254</offset><text>Future research should aim to clarify the mechanisms underpinning the relationship between research recruitment and patient-reported quality of care. Qualitative studies involving both service users and care providers could explore how research engagement directly and indirectly influences day-to-day care delivery. Such work may build a comprehensive understanding of how co-existing service features interact with research engagement, thereby informing service design. It could also provide valuable insights into barriers to research participation for centres not currently recruiting, addressing an important unmet need. Longitudinal studies examining changes in patient-reported quality of care before and after the implementation of research programmes would also help determine whether research engagement exerts a causal effect on patient-reported care quality. Similar studies in other chronic conditions could also clarify if the effects seen are specific to IBD or generalisable across disease areas.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>32267</offset><text>In conclusion, this study, drawing on two independent national datasets, demonstrates a positive association between the research activity of IBD services and patient-reported quality of care from service users. Importantly, this relationship remained robust after adjusting for key service factors, supporting the generalisability of the findings. Furthermore, offering patients research opportunities was positively correlated with both higher reported care quality and greater research recruitment. Together, these findings strengthen the case for embedding research activity into routine care and underscore the implications for service design, workforce planning and the prioritisation of research engagement within clinical practice.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>33007</offset><text>Supplementary material</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>33030</offset><text>Funding: Crohn’s &amp; Colitis UK-funded staff and IBD Registry-funded staff were involved in the development and delivery of the IBD UK benchmarking survey (grant no: NA).</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>33201</offset><text>Provenance and peer review: Not commissioned; externally peer reviewed.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>33273</offset><text>Patient consent for publication: Not applicable.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>33322</offset><text>Ethics approval: This study involves human participants but was not approved. Benchmarking surveys were designed and delivered by IBD UK, Crohn’s &amp; Colitis UK and the IBD Registry. The IBD Registry coordinated data collection and acted as data controller. All participant data were collected and analysed in anonymous form. As an anonymous survey from a patient organisation, ethical approval was not required.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>33735</offset><text>Data availability free text: IBD UK Benchmarking data is available upon application to IBD UK. Data on NIHR Portfolio studies is collated by the Research Delivery Network and shared with all NHS Organisations. NIHR CPMS data is available upon application to the NIHR.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>34003</offset><text>Collaborators: 1. Contributors to the IBD UK Task &amp; Finish Group: Katie Adams, Rachel Ainley, Ian Arnott,</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>34109</offset><text>Sarah Bayliss, Graham Bell, Kathleen Bone, Seema Buckley, Angela Chana, J R Fraser Cummings, Shahida Din, Liz Dobson, Fiona Eldridge, Jonathan Evans, Melissa Ganendran, Wendi Harrison, A Barney Hawthorne, Katie Keetarut, Alexandra Kent, Jon Kwok, Christopher A Lamb, Jimmy K Limdi, Charles Maxwell-Armstrong, Gayle Martin, Gareth C Parkes, Emma Pryde, Mohammed Nabil Quraishi, Marianne Radcliffe, Fiona Rees, Jenna Robinson, Ruth Rudling, Christian P Selinger, Esha Sharma, Sarah Sleet, Ben Skipp, Anwen Thomas, Jess Turner, Ruth Wakeman, Catherine Winsor, Lisa Younge. 2. IBD Service Survey Collaborators**Mostafa Afifi, Lucy Aitchison, Gill Anderson, Gillian Bain, Zahra Bayaty, Pauline Bell, James Berrill, Sophia Bishop, Paul Blaker, Keith Bodger, Dulini Broomhall, Victoria Burn, Jeffrey R Butterworth, Vida Cairnes, Rachel Campbell, Julie Carris-Wright, Rowena Castillo, Louise Caulfield, Alex Cheshire, Daljit Chohan, Marion Clark, Katie Clark, Carol Cobb, Josephine Coe, Rachel Cooney, Lourdes Cumlat, Patricia Daly, Anups De Silva, Anjan Dhar, Benjamin Disney, Fiona Donovan, Helen Empson, Bridgette Fraser, Aileen Fraser, Becky George, Nivedita Ghosh, Lynn Gray, James Gulliver, Anton Gunasekera, Markus Gwiggner, Sarah Harrison, Wendi Harrison, Virginia Hay, Caroline Hayhurst, Patricia Hooper, Louise Horne, Hasnain Jafferbhoy, Kerrie Johns, Emma Johnston, Karen Kemp, Dawn Kilpatrick, Matthew Kirkbride, Beverley Kirkham, Andrew Kneebone, Ioannis Koumoutsos, Christopher A Lamb, Lianne Lewis, James O Lindsay, Amy Lloyd, Caroline Lock, Helen Ludlow, Clare Macpherson, Anne Macrae, Philip Mairs, Gayle Martin, Joy Mason, Kirsten Mccaul, Gordon McFarlane, Ross McGettigan, Vidya Morgan, Deborah Morris, Graham Morrison, Themba Mudege, Ann Muir, Jasbir Nahal, Mark Narain, Ebenezer Nellikunnil, Elizabeth Nelson, Emma Nowell, Arabis Oglesby, Joanne Owens, Hari Padmanabhan, Lauren Laydon Parkin, Jacqueline Paterson, Polychronis Pavlidis, Simon Peake, Mohammad Farhad Peerally, Kathryn Phillis, Tim Raine, Maxine Rawle, Shuvra Ray, Ian Reilly, Kerry Robinson, Jenna Robinson, Matthew D Rutter, Linda Samuel Tuck, Glyn Scott, Shaji Sebastian, Christian P Selinger, Caroline Sharratt, Ian Shaw, Jayne Slater, Melissa A Smith, Samuel Smith, Katie Smith, Amudha Somasekar, Sunil Sonwalkar, Seth Squires, Alan Steel, Samuel Sunil, Diarmid Sutherland, Nora Thoua, Diane Upton, Jennifer Veryan, Aldea Waters, Susie Wen, Lydia White, Simon R Whiteoak, Sarra Wilcox, Lisa Younge, Pam Younge.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>36602</offset><text>References</text></passage><passage><infon key="fpage">203</infon><infon key="lpage">8</infon><infon key="name_0">surname:Jonker;given-names:L</infon><infon key="name_1">surname:Fisher;given-names:SJ</infon><infon key="name_2">surname:Dagnan;given-names:D</infon><infon key="pub-id_doi">10.1111/jep.13118</infon><infon key="pub-id_pmid">30784152</infon><infon key="section_type">REF</infon><infon key="source">J Eval Clin Pract</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>36613</offset><text>Patients admitted to more research-active hospitals have more confidence in staff and are better informed about their condition and medication: Results from a retrospective cross-sectional study</text></passage><passage><infon key="elocation-id">e0118253</infon><infon key="name_0">surname:Ozdemir;given-names:BA</infon><infon key="name_1">surname:Karthikesalingam;given-names:A</infon><infon key="name_2">surname:Sinha;given-names:S</infon><infon key="pub-id_doi">10.1371/journal.pone.0118253</infon><infon key="pub-id_pmid">25719608</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2015</infon><offset>36808</offset><text>Research activity and the association with mortality</text></passage><passage><infon key="fpage">89</infon><infon key="lpage">96</infon><infon key="name_0">surname:Downing;given-names:A</infon><infon key="name_1">surname:Morris;given-names:EJ</infon><infon key="name_2">surname:Corrigan;given-names:N</infon><infon key="pub-id_doi">10.1136/gutjnl-2015-311308</infon><infon key="pub-id_pmid">27797935</infon><infon key="section_type">REF</infon><infon key="source">Gut</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">2017</infon><offset>36861</offset><text>High hospital research participation and improved colorectal cancer survival outcomes: a population-based study</text></passage><passage><infon key="fpage">184</infon><infon key="lpage">93</infon><infon key="name_0">surname:Fanaroff;given-names:AC</infon><infon key="name_1">surname:Vora;given-names:AN</infon><infon key="name_2">surname:Chen;given-names:AY</infon><infon key="pub-id_doi">10.1016/j.ahj.2019.05.011</infon><infon key="pub-id_pmid">31234037</infon><infon key="section_type">REF</infon><infon key="source">Am Heart J</infon><infon key="type">ref</infon><infon key="volume">214</infon><infon key="year">2019</infon><offset>36973</offset><text>Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">6</infon><infon key="name_0">surname:Jonker;given-names:L</infon><infon key="name_1">surname:Fisher;given-names:SJ</infon><infon key="pub-id_doi">10.1016/j.puhe.2017.12.022</infon><infon key="section_type">REF</infon><infon key="source">Public Health (Fairfax)</infon><infon key="type">ref</infon><infon key="volume">157</infon><infon key="year">2018</infon><offset>37117</offset><text>The correlation between National Health Service trusts’ clinical trial activity and both mortality rates and care quality commission ratings: a retrospective cross-sectional study</text></passage><passage><infon key="fpage">625</infon><infon key="lpage">45</infon><infon key="name_0">surname:Hawthorne;given-names:AB</infon><infon key="name_1">surname:Glatter;given-names:J</infon><infon key="name_2">surname:Blackwell;given-names:J</infon><infon key="pub-id_doi">10.1111/apt.17042</infon><infon key="pub-id_pmid">35770866</infon><infon key="section_type">REF</infon><infon key="source">Aliment Pharmacol Ther</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">2022</infon><offset>37299</offset><text>Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patients</text></passage><passage><infon key="comment">Available</infon><infon key="element-citation">https://ibduk.org/about-ibd-uk</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2019</infon><offset>37443</offset><text>About IBD UK</text></passage><passage><infon key="fpage">178</infon><infon key="lpage">87</infon><infon key="name_0">surname:Kapasi;given-names:R</infon><infon key="name_1">surname:Glatter;given-names:J</infon><infon key="name_2">surname:Lamb;given-names:CA</infon><infon key="pub-id_doi">10.1136/flgastro-2019-101260</infon><infon key="pub-id_pmid">32419908</infon><infon key="section_type">REF</infon><infon key="source">Frontline Gastroenterol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>37456</offset><text>Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK</text></passage><passage><infon key="comment">Available</infon><infon key="element-citation">https://ibduk.org/reports/2024-ibd-uk-report-the-state-of-ibd-care-in-the-uk</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2024</infon><offset>37556</offset><text>IBD UK report: the state of ibd care in the uk</text></passage><passage><infon key="fpage">377</infon><infon key="lpage">81</infon><infon key="name_0">surname:Harris;given-names:PA</infon><infon key="name_1">surname:Taylor;given-names:R</infon><infon key="name_2">surname:Thielke;given-names:R</infon><infon key="pub-id_doi">10.1016/j.jbi.2008.08.010</infon><infon key="pub-id_pmid">18929686</infon><infon key="section_type">REF</infon><infon key="source">J Biomed Inform</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2009</infon><offset>37603</offset><text>Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support</text></passage><passage><infon key="comment">Available</infon><infon key="element-citation">https://www.nihr.ac.uk/getting-started-and-logging-cpms</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2019</infon><offset>37754</offset><text>Getting started and logging in to CPMS</text></passage><passage><infon key="comment">n.d. Available</infon><infon key="element-citation">https://www.nihr.ac.uk/glossary</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>37793</offset><text>NIHR Glossary</text></passage><passage><infon key="comment">n.d. Available</infon><infon key="element-citation">https://ibduk.org/reports/ibd-uk-2023-benchmarking-survey-results</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>37807</offset><text>IBD UK 2023 benchmarking survey results</text></passage><passage><infon key="fpage">vii16</infon><infon key="lpage">9</infon><infon key="name_0">surname:Rochon;given-names:J</infon><infon key="name_1">surname:du Bois;given-names:A</infon><infon key="pub-id_doi">10.1093/annonc/mdr421</infon><infon key="pub-id_pmid">22039139</infon><infon key="section_type">REF</infon><infon key="source">Ann Oncol</infon><infon key="type">ref</infon><infon key="volume">22 Suppl 7</infon><infon key="year">2011</infon><offset>37847</offset><text>Clinical research in epithelial ovarian cancer and patients’ outcome</text></passage><passage><infon key="fpage">145</infon><infon key="lpage">56</infon><infon key="name_0">surname:Liu;given-names:Z</infon><infon key="name_1">surname:Le;given-names:K</infon><infon key="name_2">surname:Zhou;given-names:X</infon><infon key="pub-id_doi">10.1016/S2468-1253(22)00389-2</infon><infon key="pub-id_pmid">36481043</infon><infon key="section_type">REF</infon><infon key="source">Lancet Gastroenterol Hepatol</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2023</infon><offset>37918</offset><text>Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study</text></passage><passage><infon key="fpage">190</infon><infon key="lpage">8</infon><infon key="name_0">surname:Chee;given-names:D</infon><infon key="name_1">surname:Nice;given-names:R</infon><infon key="name_2">surname:Hamilton;given-names:B</infon><infon key="pub-id_doi">10.1093/ecco-jcc/jjab128</infon><infon key="pub-id_pmid">34289028</infon><infon key="section_type">REF</infon><infon key="source">J Crohns Colitis</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2022</infon><offset>38205</offset><text>Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for Therapeutic Drug Monitoring in patients with Inflammatory Bowel Disease</text></passage><passage><infon key="comment">Available</infon><infon key="element-citation">https://www.nihr.ac.uk/news/nihr-issues-final-update-implementation-restart-framework</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>38355</offset><text>NIHR issues final update on implementation of the restart framework</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>38423</offset><text>Data availability statement</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>38451</offset><text>Data may be obtained from a third party and are not publicly available.</text></passage></document>
</collection>